Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.96 |
| ▸ | PPARG | P37231 | 8/20 | 0.96 |
| ▸ | F7 | P08709 | 7/20 | 0.96 |
| ▸ | F3 | P13726 | 7/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.96 |
| ▸ | PPARD | Q03181 | 6/20 | 0.96 |
| ▸ | PPARA | Q07869 | 6/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.96 |
| ▸ | MAPT | P10636 | 4/20 | 0.96 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | LMNA | P02545 | 3/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.96 |
| ▸ | HPGD | P15428 | 3/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7750567 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL452559 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL454567 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL4452324 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL10444556 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL7755119 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL14119798 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL7750573 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL15994740 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL29226 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642830-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA France (FR) | 2025-11-05 | — | — | EP | claimed |
| WO-2025093572-A1 | SOLID DISPERSION COMPOSITIONS AND USES THEREOF | TRx Biosciences Limited (GB) | 2025-05-08 | — | — | WO | claimed |
| CN-119677509-A | Fibrate composition for the treatment of inflammation and neuroinflammation | 特瑞克思生物科学有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4493151-A2 | COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS AND USES THEREOF | TRX Biosciences Limited (GB) | 2025-01-22 | — | — | EP | claimed |
| WO-2024141286-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| EP-4312978-A2 | COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS | TRX Biosciences Limited (GB) | 2024-02-07 | — | — | EP | claimed |
| US-11771708-B2 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | GREENWOOD BRANDS, LLC (US) | 2023-10-03 | — | — | US | claimed |
| WO-2023174948-A2 | COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS AND USES THEREOF | TRx Biosciences Limited (GB) | 2023-09-21 | — | — | WO | claimed |
| EP-4125820-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF PH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | PLx Opco Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| CN-115666523-A | Drug carriers capable of pH dependent reconstitution and methods of making and using the same | PLX 奥普科有限公司 | 2023-01-31 | — | — | CN | claimed |
| US-7316816-B2 | Temperature and pH sensitive copolymers | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2008-01-08 | — | — | US | claimed |
| EP-1765894-A1 | NOVEL TEMPERATURE AND PH SENSITIVE COPOLYMERS | Agency for Science, Technology and Research (SG) | 2007-03-28 | — | — | EP | claimed |
| WO-2005121196-A1 | NOVEL TEMPERATURE AND PH SENSITIVE COPOLYMERS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2005-12-22 | — | — | WO | claimed |
| US-20050277739-A1 | Amphiphilic terpolymer having pH-sensitive hydrophobic units derived from a polyunsaturated fatty acid (9,12-Octadecadienoic Acid), hydrophilic units with polar groups (acrylic acid), and temperature-sensitive units (acryloylpiperidine); lower critical solution temperature decreases as pH decreases | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH | 2005-12-15 | — | — | US | claimed |
| EP-1417629-A4 | GENERATING, VIEWING, INTERPRETING, AND UTILIZING A QUANTITATIVE DATABASE OF METABOLITES | LIPOMICS TECHNOLOGIES INC (US) | 2005-08-17 | — | — | EP | claimed |
| US-20050013867-A1 | Use of proton sequestering agents in drug formulations | NOVARTIS PHARMA AG (CH) | 2005-01-20 | — | — | US | claimed |
| US-20040143461-A1 | Generating, viewing, interpreting, and utilizing a quantitative database of metabolites | LIPOMICS TECHNOLOGIES, INC. | 2004-07-22 | — | — | US | claimed |
| EP-1417629-A2 | GENERATING, VIEWING, INTERPRETING, AND UTILIZING A QUANTITATIVE DATABASE OF METABOLITES | Lipomics Technologies, Inc. (US) | 2004-05-12 | — | — | EP | claimed |
| WO-2003035051-A2 | THE USE OF PROTON SEQUESTERING AGENTS IN DRUG FORMULATIONS | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 2003-05-01 | — | — | WO | claimed |
| WO-2003005628-A2 | GENERATING, VIEWING, INTERPRETING, AND UTILIZING A QUANTITATIVE DATABASE OF METABOLITES | LIPOMICS TECHNOLOGIES, INC. (US) | 2003-01-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11771708-B2 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | ABCB11, SLC47A1, SLC46A1 | ALDH1A1 2155/4885PPARG 4842/4885F7 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.